Literature DB >> 22633108

Treatment outcome of nasopharyngeal carcinoma with retropharyngeal lymph nodes metastasis only and the feasibility of elective neck irradiation.

Xiaomin Ou1, Chunying Shen1, Lin Kong1, Xiaoshen Wang1, Jianhui Ding2, Yunsheng Gao1, Tingting Xu1, Chaosu Hu3.   

Abstract

OBJECTIVE: To investigate the outcome of nasopharyngeal carcinoma (NPC) with retropharyngeal lymph nodes (RLNs) metastasis only and evaluate the feasibility of elective neck irradiation.
MATERIALS AND METHODS: This is a retrospective study of 119 newly diagnosed non-metastatic NPC patients with RLNs metastasis only. All of them received definitive radiotherapy. Eighty nine patients received elective neck irradiation to levels II, III, VA and the rest received whole neck irradiation, including levels II-V.
RESULTS: The median follow-up was 36.6 months. The 5-year local recurrence-free survival (LFS), nodal recurrence-free survival (NFS), distant metastasis-free survival (DMFS) and overall survival (OS) was 81.4%, 92.7%, 91.8%, and 93.6%, respectively. Four patients developed nodal relapse and only one was out-of-field relapse. No significant difference of nodal recurrence was observed between elective neck irradiation and whole neck irradiation. IMRT or three-dimensional conformal radiotherapy (3D-CRT) showed a trend of improving regional control, compared with conventional two-dimensional radiotherapy (2D-RT) (p=0.074). In 2D-RT, a higher dose (>5600 cGy) to the upper neck showed a benefit of regional control(p=0.006). Multivariate analysis demonstrated that only the dose of upper neck was an independent prognostic factor of NFS.
CONCLUSIONS: Elective irradiation to levels II, III, VA was not inferior to whole neck irradiation for NPC patients with RLNs metastasis only. However, more evidences are needed to confirm the result. IMRT showed a trend of improving regional control. A higher dose of prophylactic radiation may be required for upper neck region in patients with RLNs metastasis.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22633108     DOI: 10.1016/j.oraloncology.2012.04.011

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  10 in total

1.  Omitting the lower neck and sparing the glottic larynx in node-negative nasopharyngeal carcinoma was safe and feasible, and improved patient-reported voice outcomes.

Authors:  F Xiao; S Dou; Y Li; W Qian; F Liang; L Kong; X Wang; K Wu; C Hu; G Zhu
Journal:  Clin Transl Oncol       Date:  2018-12-04       Impact factor: 3.405

Review 2.  Quality of Life, Toxicity and Unmet Needs in Nasopharyngeal Cancer Survivors.

Authors:  Lachlan McDowell; June Corry; Jolie Ringash; Danny Rischin
Journal:  Front Oncol       Date:  2020-06-12       Impact factor: 6.244

3.  Contralateral Lower Neck Sparing Radiotherapy in Stage N1 Nasopharyngeal Carcinoma: Long-Term Survival Outcomes and Late Toxicities.

Authors:  Zhuang Sun; Jingyun Wang; Runda Huang; Xiaohui Wang; Chunyan Chen; Meiling Deng; Chong Zhao; Hanyu Wang; Fei Han
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

Review 4.  Emerging treatment options for nasopharyngeal carcinoma.

Authors:  Lu Zhang; Qiu-Yan Chen; Huai Liu; Lin-Quan Tang; Hai-Qiang Mai
Journal:  Drug Des Devel Ther       Date:  2013-02-01       Impact factor: 4.162

5.  Locoregional extension patterns of nasopharyngeal carcinoma and suggestions for clinical target volume delineation.

Authors:  Wen-Fei Li; Ying Sun; Mo Chen; Ling-Long Tang; Li-Zhi Liu; Yan-Ping Mao; Lei Chen; Guan-Qun Zhou; Li Li; Jun Ma
Journal:  Chin J Cancer       Date:  2012-08-02

6.  The feasibility of omitting irradiation to the contralateral lower neck in stage N1 nasopharyngeal carcinoma patients.

Authors:  Weixu Hu; Guopei Zhu; Xiyin Guan; Xiaoshen Wang; Chaosu Hu
Journal:  Radiat Oncol       Date:  2013-10-04       Impact factor: 3.481

7.  Patterns of local failures and suggestions for reduction of clinical target volume for nasopharyngeal carcinoma patients without cervical lymph node metastasis.

Authors:  Yujiao Li; Xiaomin Ou; Chunying Shen; Tingting Xu; Weiwei Li; Chaosu Hu
Journal:  Onco Targets Ther       Date:  2018-05-07       Impact factor: 4.147

8.  Evidence on Effectiveness of Upper Neck Irradiation Versus Whole Neck Irradiation as Elective Neck Irradiation in Node-Negative Nasopharyngeal Cancer: A Meta-Analysis.

Authors:  Jayson L Co; Michael Benedict A Mejia; Janine Margarita R Dizon
Journal:  J Glob Oncol       Date:  2016-11-30

9.  Feasibility of ipsilateral lower neck sparing irradiation for unilateral or bilateral neck node-negative nasopharyngeal carcinoma: systemic review and meta-analysis of 2, 521 patients.

Authors:  Cheng-Long Huang; Cheng Xu; Yuan Zhang; Guan-Qun Zhou; Yan-Ping Mao; Qing Liu; Ying Sun; Jun Ma; Ling-Long Tang
Journal:  Radiat Oncol       Date:  2018-08-06       Impact factor: 3.481

10.  Verification of the Efficacy of New Diagnostic Criteria for Retropharyngeal Nodes in a Cohort of Nasopharyngeal Carcinoma Patients.

Authors:  Dom-Gene Tu; Hsuan-Yu Chen; Wei-Jen Yao; Yu-Sheng Hung; Yu-Kang Chang; Chih-Han Chang; Yu-Wen Wang
Journal:  Int J Med Sci       Date:  2021-08-13       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.